Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial G. Prieur (Brussels, Belgium), C. Medrinal (Rouen, France), Y. Combret (Brussels, Belgium), E. Dupuis Lozeron (Geneva, Switzerland), T. Bonnevie (Rouen, France), F. Gravier (Rouen, France), J. Quieffin (montivilliers, France), B. Lamia (Rouen, France), J. Borel (Grenoble, France), G. Reychler (Brussels, Belgium)
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Disease area: Airway diseasesRating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Prieur (Brussels, Belgium), C. Medrinal (Rouen, France), Y. Combret (Brussels, Belgium), E. Dupuis Lozeron (Geneva, Switzerland), T. Bonnevie (Rouen, France), F. Gravier (Rouen, France), J. Quieffin (montivilliers, France), B. Lamia (Rouen, France), J. Borel (Grenoble, France), G. Reychler (Brussels, Belgium). Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial. 2453
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial Source: Virtual Congress 2021 – New trends in non-invasive respiratory support Year: 2021
ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016 Year: 2017
Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019 Year: 2020
Acute effects of non-invasive ventilation during exercise in hypercapnic COPD patients – preliminary results of a randomized cross-over trial Source: International Congress 2017 – Best abstracts in physical activity and management of COPD Year: 2017
A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006
Domiciliary high-flow nasal cannula oxygen therapy for stable hypercapnic chronic obstructive pulmonary disease: a prospective, multicentre, randomised crossover trial Source: International Congress 2017 – New insights in chronic respiratory failure Year: 2017
The effect of bronchodilators in the exercise capacity and thoracoabdominal mechanics of subjects with bronchiectasis: a randomized crossover, double-blinded, placebo-controlled trial Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020
A randomised controlled trial of zafirlukast in acute asthma Source: Eur Respir J 2005; 26: Suppl. 49, 254s Year: 2005
A randomised double-blind placebo-controlled trial of the effect of inhaled heparin on lung function, hyperinflation and exercise capacity in patients with COPD Source: International Congress 2016 – Novel insights into the treatment of COPD Year: 2016
A randomised placebo-controlled trial of doxapram in acute hypercapnic respiratory failure complicating exacerbation of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 444s Year: 2003
Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study Source: Eur Respir J, 58 (1) 2001798; 10.1183/13993003.01798-2020 Year: 2021
Nasal high-flow oxygen versus noninvasive ventilation in acute exacerbation of COPD: protocol for a randomised noninferiority clinical trial Source: ERJ Open Res, 6 (4) 00114-2020; 10.1183/23120541.00114-2020 Year: 2020
Randomized controlled trial of nebulized budesonide suspension in acute severe exacerbation of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 244s Year: 2002
Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial Source: ERJ Open Res, 7 (3) 00738-2020; 10.1183/23120541.00738-2020 Year: 2021
Azithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial. Source: Virtual Congress 2020 – Chronic cough: only symptom or disease? Year: 2020
High flow nasal cannula during walking in severe COPD patients: a randomized controlled trial. Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases Year: 2018
A double-blind double dummy randomised placebo-controlled cross-over design clinical trial of formoterol delivered by two different dry powder devices in prevention of bronchoconstriction induced by methacholine in mild to moderate persistent asthma in adult patients Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009
Humidified and standard oxygen therapy in acute severe asthma in children: a randomised controlled pilot trial (HUMOX) Source: International Congress 2018 – Paediatric asthma: prevention, diagnosis and treatment Year: 2018
Oxygen compared to air driven nebulisers for acute exacerbations of COPD: a randomised controlled trial. Source: International Congress 2017 – COPD management Year: 2017
Antibiotic in non-purulent hospitalised-treated exacerbations of COPD: a randomised double-blind placebo-controlled trial Source: International Congress 2019 – Airway infection in COPD Year: 2019